07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

UGTKO<br />

60351<br />

Mutation<br />

Clinical Information: Bilirubin, resulting from the breakdown of heme, is a water-insoluble toxic<br />

compound. Uridine diphosphate (UDP)-glucuronosyl transferase 1A1 (UGT1A1) is responsible for<br />

bilirubin conjugation with glucuronic acid. This renders the bilirubin water soluble and permits excretion<br />

of the bilirubin-glucuronide conjugates in urine.(1) Genetic mutations in the UGT1A1 gene may cause<br />

reduced or absent UGT1A1 enzymatic activity resulting in hyperbilirubinemia (eg, Gilbert syndrome,<br />

Crigler-Najjar syndrome). Gilbert syndrome, found in 5% to 10% of the population, is the most common<br />

hereditary cause of increased bilirubin and is associated with mild hyperbilirubinemia (bilirubin levels are<br />

typically around 3 mg/dL.(2) Gilbert syndrome is caused by a 25% to 50% reduced glucuronidation<br />

activity of the UGT1A1 enzyme and characterized by episodes of mild intermittent jaundice and the<br />

absence of liver disease. Crigler-Najjar (CN) types I and II are inherited causes of severe unconjugated<br />

hyperbilirubinemia. CN type I is associated with no UGT1A1 enzymatic activity and usually presents as<br />

intense jaundice in the first days of life and persists thereafter.(3) Type II is a milder form in which<br />

bilirubin levels are

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!